Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,212,208 papers from all fields of science
Search
Sign In
Create Free Account
maroxepin
Known as:
maroxepine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Dibenzazepines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Characterization of insect neuronal octopamine receptors (OA3 receptors)
T. Roeder
,
J. Nathanson
Neurochemical Research
2005
Corpus ID: 21168001
Octopamine receptors in the nervous tissue of insects were investigated using a ligand-receptor assay with [3H]NC-5Z or [3H…
Expand
Review
1995
Review
1995
Pharmacology and molecular biology of octopamine receptors from different insect species.
T. Roeder
,
J. Degen
,
C. Dyczkowski
,
M. Gewecke
Progress in brain research
1995
Corpus ID: 8956404
1991
1991
Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine.
W. Herrmann
,
E. Schärer
,
A. Delini-Stula
Pharmacopsychiatry
1991
Corpus ID: 3148554
The present paper forms the first part of a contribution to a comprehensive critical evaluation of the use of pharmaco…
Expand
1991
1991
Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
W. Herrmann
,
E. Schärer
,
G. Wendt
,
A. Delini-Stula
Pharmacopsychiatry
1991
Corpus ID: 12601957
This publication forms the third part of a critical evaluation of pharmaco-EEG applications as an instrument for assessing the…
Expand
Highly Cited
1990
Highly Cited
1990
High-affinity antagonists of the locust neuronal octopamine receptor.
T. Roeder
European journal of pharmacology
1990
Corpus ID: 10450409
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE